ANOTHER Blow to Antidepressants—Now Tied to Faster Dementia Decline
We’ve already warned you about antidepressants and their hidden dangers.
Now, new research has uncovered an even more alarming risk—for dementia patients, these drugs may actually speed up cognitive decline, increase fractures, and even raise the risk of early death.
Yet, Big Pharma continues to push them as a first-line treatment for depression in seniors.
Are we witnessing yet another case of profits over patient safety?
A new study from Sweden’s Karolinska Institute analyzed over 18,000 dementia patients and found that those who took SSRIs (selective serotonin reuptake inhibitors)—one of the most commonly prescribed antidepressants—experienced:
- Faster cognitive decline—patients on SSRIs lost more brain function each year than those not on the drugs.
- Higher fracture risk—suggesting neurological side effects like dizziness or weakened bones.
- Increased risk of early death—patients on SSRIs were more likely to die from any
This should be headline news.
But instead? Doctors continue prescribing these drugs without warning patients of the potential risks.
Here’s the ugly truth:
For years, antidepressants have been marketed as a safe and necessary treatment for mental health issues in seniors.
But time and time again, research exposes the dark side of these drugs:
- They’ve been linked to dementia risk.
- They can worsen cognitive function.
- They increase fall and fracture risk.
- They cause dependency, making withdrawal nearly impossible.
And now, we know they could be accelerating the very disease they’re often prescribed to “help” treat.
If SSRIs were a nutritional supplement with this many risks, the FDA would ban them immediately.
But because they are a multi-billion-dollar industry, these drugs remain on the market—with no urgent warnings from the medical establishment.
Big Pharma’s goal is NOT to cure mental illness—it’s to create lifelong customers. Antidepressants keep patients dependent, needing more drugs to manage side effects.
And when those drugs lead to fractures, dementia, or death? More prescriptions, more profits.
This is the same playbook they’ve used for opioids, benzodiazepines, and statins.
And dementia patients—already vulnerable—are now the latest victims of a profit-driven system.
The good news? You don’t need to rely on Big Pharma’s dangerous antidepressants to support brain health.
Here are safer, natural approaches that support both mood and cognition:
- Omega-3 fatty acids – Found in wild fish and algae supplements, these fats support brain function and mood stability.
- Turmeric (curcumin) – A powerful anti-inflammatory that has been shown to improve memory and ease depression naturally.
- Magnesium – Known as the “relaxation mineral,” magnesium supports mood, sleep, and cognitive function.
- Adaptogenic herbs (like ashwagandha & rhodiola) – These natural remedies help balance stress hormones and combat anxiety.
- Regular exercise and sunlight exposure – Both have been proven to boost mood and slow cognitive decline—without a single side effect.
It’s no secret that we’ve been skeptical of antidepressants for a long time.
And now, the science is catching up.
These drugs aren’t just ineffective for many people—they may be making things WORSE.
Dementia patients deserve better.
And so do you.
To brain health, the right way,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
Sources:
McRae, M. (2025, February 25). Some Antidepressants Could Speed Decline in Dementia Patients. ScienceAlert. https://www.sciencealert.com/some-antidepressants-could-speed-decline-in-dementia-patients


